Kelun-Biotech’s Sac-TMT shows breakthrough results in first-line lung cancer trial
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Call it a ray of hope for those enduring the pain of knee osteoarthritis -- the most common form of arthritis, affecting over 300 million people worldwide
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
The positive outcome clears the way for Glenmark to resume commercial manufacturing at the site
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Surgical site infections and antimicrobial resistance remain major challenges globally
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Subscribe To Our Newsletter & Stay Updated